EX-99.2 3 tm2522365d1_ex99-2.htm EXHIBIT 99.2

 

Exhibit 99.2

 

 

2Q 2025 Earnings Presentation August 2025

 

 

FORWARD - LOOKING STATEMENTS Statements made in this presentation regarding American Public Education, Inc . or its subsidiary institutions (“APEI” or the “Company”) that are not historical facts are forward - looking statements based on current expectations, assumptions, estimates and projections about APEI and the industry . In some cases, forward looking statements can be identified by words such as “anticipate,” “believe,” “seek,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potentially,” “project,” “should,” “will,” “would,” and similar words or their opposites . Forward - looking statements include, without limitation, statements regarding expectations for growth, registration, enrollments, demand, revenues, net income, earnings per share, EBITDA and Adjusted EBITDA, capital expenditures, free cash flow, and plans with respect to and future impacts of recent, current and future initiatives, including the planned combination of APUS, RU and HCN into one consolidated institution, campus and corporate center consolidation, and redemption of preferred stock . Forward - looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements . Such risks and uncertainties include, among others, risks related to : the Company’s failure to comply with regulatory and accrediting agency requirements, including the “ 90 / 10 Rule”, and to maintain institutional accreditation and the impacts of any actions the Company may take to prevent or correct such failure ; changes in the postsecondary education regulatory environment as a result of U . S . federal elections, including any changes by or as a result of actions of the current administration to the operations of the Department of Education or changes to or the elimination or implementation of laws, regulations, standards, policies, and practices ; potential or actual government shutdowns, as well as government budget and federal workforce uncertainty ; the impact, timing, and projected benefits of the planned combination the Company’s dependence on the effectiveness of its ability to attract students who persist in its subsidiary institutions’ programs ; declines in enrollments at the Company’s subsidiary institutions ; the Company’s inability to effectively brand or market its subsidiary institutions and its subsidiary institutions’ programs ; the Company’s inability to maintain strong relationships with the military and maintain course registrations and enrollments from military students ; the loss or disruption of the Company’s ability to receive funds under Title IV or tuition assistance programs or the reduction, elimination, or suspension of federal funds ; adverse effects of changes the Company makes to improve the student experience and enhance the ability to identify and enroll students who are likely to succeed ; the Company’s need to successfully adjust to future market demands including updating existing programs and developing new programs ; the Company’s loss of eligibility to participate in Title IV programs or ability to process Title IV financial aid ; economic and market conditions and changes in interest rates ; difficulties involving acquisitions ; the Company’s indebtedness and preferred stock, including the refinancing or redemption thereof ; the Company’s dependence on and the need to continue to invest in its technology infrastructure, including with respect to third - party vendors ; the inability to recognize the anticipated benefits of the Company’s cost savings and revenue generating efforts ; the Company’s ability to manage and limit its exposure to bad debt ; and the risk factors described in the risk factor section and elsewhere in the Company’s most recent annual report on Form 10 - K and quarterly report on Form 10 - Q and in the Company’s other SEC filings . You should not place undue reliance on any forward - looking statements . The Company undertakes no obligation to update publicly any forward - looking statements for any reason, unless required by law, even if new information becomes available or other events occur in the future .

 

 

2Q’25 Executive Summary $162.8 M Revenue $15.1 M Adj. EBITDA 1 ($0.3) M Net loss available to common stockholders $176.6 M Cash (as of 6/30/25) 1. Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization, less non - recurring expenses, such as severanc e, and non - cash expenses, such as stock compensation) and EBITDA are non - GAAP financial measures. Please refer to Appendix for GAAP to non - GAAP reconciliation. ($0.02) Diluted EPS ▪ 2Q’25 results above guidance include: x Revenue of $162.8 million x Net loss available to common stockholders of ($0.3) million vs ($1.2) million in 2Q’24 x Adjusted EBITDA 1 of $15.1 million vs $10.9 million in 2Q’24 ▪ Redemption of preferred stock 2Q’25 Business Highlights APEI is a market leader in the post - secondary education of active - duty military, veterans, new nurses, and health professionals, segments that have demonstrated stable and long - term demand. 2Q’25 Financial Highlights +7% YoY +38% YoY +13% YoY ▪ APUS increased net course registrations by 7.3% vs 2Q’24 ▪ Rasmussen increased enrollment by 10.4% in 3Q’25 x Fifth consecutive quarter of YoY enrollment growth x 2Q25 EBITDA of $0.2 million vs 2Q24 of ($4.7M) ▪ Hondros College of Nursing (HCN) increased enrollment 17.6% enrollment vs 3Q’24 ($1.2 M) in 2Q’24 ($0.06) in 2Q’24 Enrollment Highlights 3 Subsequent Event ▪ APEI completed the sale of GSUSA, including the transfer of the lease obligation on July 25, 2025

 

 

Financial Highlights APEI is a market leader in the post - secondary education of active - duty military, veterans, new nurses, and health professionals, segments that have demonstrated stable and long - term demand. 3Q’25 and Full Year 2025 Guidance $650M - $660M 2025E Revenue $18M - $24M 2025E Net income available to common stockholders $81M - $88M 2025E Adj. EBITDA 1 ▪ APUS 3Q’25 expected registration growth of 5% - 7% compared to 3Q’24 ▪ Rasmussen 3Q’25 enrollment growth up 10% vs 3Q’24 ▪ HCN 2Q’25 enrollment growth up 18% vs 3Q’24 ▪ Net income guidance includes the loss on sale of GSUSA 1. Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization, less non - recurring expenses, such as severanc e, and non - cash expenses, such as stock compensation) is a non - GAAP financial measure. Please refer to Appendix for GAAP to non - GAAP reconciliation. ▪ Full year 2025 Net income guidance of $18 - $24 million ▪ Net income guidance includes the loss on sale of GSUSA ▪ Raising full year 2025 Adjusted EBITDA guidance to $81 - $88 million Full Year 2025 Guidance 3Q’25 Guidance 4

 

 

Simplify & Strengthen in 2025 » Combine APUS, Rasmussen and HCN into one system x Close and consolidate campuses and corporate centers x APUS/APEI: Corporate buildings sold in June 2025 x Early redemption of preferred equity x Preferred redemption drives higher diluted EPS x Simplified capital structure x Release of $24.5 million letter of credit, which is no longer restricted cash x Complete sale of Graduate School USA 5

 

 

Registrations & Enrollments 388,400 TTM Net Course Registrations 14,900 3Q’25 Enrollment APUS has delivered consistently strong net course registrations since 2020, driven by continued strength in military and growing enrollments from veterans and military - affiliated families Year - over - year Rasmussen campus and online enrollments have been improving since 2Q’23. Rasmussen has delivered year - over - year total enrollment growth for 5 consecutive quarters HCN delivered double digit year - over - year enrollment growth 3,700 3Q’25 Enrollment 6

 

 

Enrollment Summary – Military, Veterans & their Families * Trailing 12 months quarterly registration figures ▪ Consistent, steady registration growth over past 2 years ▪ Revenue growth driven by increased net course registrations & impact of select tuition & fee increases in 2024 346,200 347,100 349,800 350,400 352,700 357,500 364,000 367,600 370,300 371,900 372,100 378,400 381,900 388,400 1Q22 2Q22 3Q22 4Q22 1Q23 2Q23 3Q23 4Q23 1Q24 2Q24 3Q24 4Q24 1Q25 2Q25 7

 

 

Enrollment Summary – Healthcare ▪ Rasmussen year - over - year enrollment trends have been improving since 2Q’23 and delivered 5 consecutive quarters of year - over - year enrollment growth ▪ Positive campus enrollment growth in 1Q’25, 2Q’25 and 3Q’25 YoY enrollment comparison by quarter YoY enrollment comparison by quarter ▪ HCN continues to deliver consistent year - over - year enrollment growth 13,500 13,500 14,100 14,600 13,500 14,500 13,600 14,600 13,500 14,900 3Q23 3Q24 4Q23 4Q24 1Q24 1Q25 2Q24 2Q25 3Q24 3Q25 2,800 3,100 3,100 3,700 3,300 3,600 3,300 3,700 3,100 3,700 3Q23 3Q24 4Q23 4Q24 1Q24 1Q25 2Q24 2Q25 3Q24 3Q25 8

 

 

Financial Update

 

 

Segment Revenue • APUS has delivered consistent year - over - year growth driven by modest increases in registrations and targeted tuition and fee increases • Rasmussen continues to build on a solid foundation with higher revenue and enrollment trends • 3Q’25 enrollment growth is 10% over 3Q’24 • Fifth consecutive quarter of year - over - year revenue growth • 2Q’25 revenue growth of 10.5% APUS increased revenue year - over - year and is expected to grow net course registrations in 2025. Rasmussen and HCN experienced year - over - year revenue growth and positive enrollment trends. $76.4 $77.0 $79.4 $82.4 $80.7 $83.9 $77.0 $81.7 3Q23 3Q24 4Q23 4Q24 1Q24 1Q25 2Q24 2Q25 $52.1 $52.6 $52.6 $57.5 $53.1 $59.3 $53.0 $59.5 3Q23 3Q24 4Q23 4Q24 1Q24 1Q25 2Q24 2Q25 $13.7 $15.5 $15.8 $18.9 $16.4 $17.7 $16.4 $18.1 3Q23 3Q24 4Q23 4Q24 1Q24 1Q25 2Q24 2Q25 10

 

 

Profitability ▪ 2Q’25 EBITDA margin of 27% on $81.7 million in revenue TTM Adj. EBITDA 1 TTM Adj. EBITDA Margin 1 ▪ Revenue growth of 12% in 2Q’25 versus 2Q’24 ▪ Rasmussen delivered $0.2 million of EBITDA in 2Q’25 compared to ($4.7) million in 2Q24 ▪ Positive 1H’25 EBITDA of $2.3M vs. 1H’24 loss of $7.4M ▪ EBITDA of $0.1 million in 2Q’25 compared to ($0.4) million in 2Q’24 ▪ HCN enrollments have grown at double - digit rates for 9 of the last 11 quarters ▪ Subsequent to quarter end, APEI closed the sale of Graduate School USA 1. Please refer to appendix for GAAP to non - GAAP reconciliation $49.3 $66.6 $59.6 $72.3 $69.6 $76.5 $71.8 $80.7 3Q23 3Q24 4Q23 4Q24 1Q24 1Q25 2Q24 2Q25 8.2% 10.9% 9.9% 11.6% 11.5% 12.1% 11.7% 12.5% 3Q23 3Q24 4Q23 4Q24 1Q24 1Q25 2Q24 2Q25 11

 

 

Balance Sheet & Cash Flow 6 Months Ended June 30, 2024 2025 in Millions ($2.2) $7.1 Net income (loss) available to common stockholders $28.0 $36.3 Adjusted EBITDA 1 $11.4 $7.6 ( - ) Capital expenditures $16.6 $28.7 Free cash flow 2 As of June 30, 2024 2025 in Millions $156.2 $176.6 Cash $26.4 $1.6 ( - ) Restricted cash $129.8 $174.9 Unrestricted cash $92.8 $94.1 Term loan $37.0 $80.9 Unrestricted cash, net of debt $39.7 $0.0 Preferred equity 17.7 18.1 Shares outstanding Strong Balance Sheet with $177M in Cash. Redeemed Preferred Stock in Q2’25 1. Please refer to appendix for GAAP to non - GAAP reconciliation 2. Free cash flow is defined as Adjusted EBITDA less capex 12

 

 

Guidance 3Q’25 ($in millions) $161 - $159 Revenue ($0.8) - ($2.9) Net Income (loss) avail to common shareholders $17 - $15 Adjusted EBITDA 1 FY 2025 $660 - $650 Revenue $24 - $18 Net Income avail to common shareholders $88 - $81 Adjusted EBITDA 1 ▪ FY2025 Revenue forecasted to be 4% - 6% higher than 2024 ▪ FY2025 Net Income guidance equals $1.00 - $1.33 per diluted share ▪ FY2025 Adjusted EBITDA 1 forecasted to be 12% - 22% higher than 2024 ▪ $18 - $22 million anticipated capex in 2025 1. Please refer to appendix for GAAP to non - GAAP reconciliation These statements are based on current expectations. These statements are forward looking and actual results may differ materially. 13

 

 

INVESTMENT HIGHLIGHTS Large Addressable Market Online education expected to increase to >$100 billion in 5 years Demand for nurses estimated to be 200,000+ per year Solid ROI for Education & Stable Long - Term Demand APUS in top 11% for student return on educational investment 1 Improving Performance and Operating Leverage Solid growth, margins and cash flow performance at APUS Rasmussen delivering positive enrollment and positive EBITDA Simplifying Business Operations Consolidating three separate institutions into one university system Redeemed preferred equity in 2Q’25 Completed sale of two corporate buildings Completed sale of GSUSA 1. According to the Georgetown University Center on Education and the Workforce (2022) 2. Free cash flow defined as Adjusted EBITDA less Capital Expenditures Strong Cash Position Free cash flow 2 expected to be $59 million to $70 million in 2025 $24.5 million of restricted cash released in 2Q’25 14

 

 

Appendix

 

 

Education Unit Profile Note: See note 16 to the financial statements included in the 2024 10 - K. Reflects income (loss) from operations before interest, income taxes, gain (loss) from acquisitions, + depreciation & amortization. Please refer to appendix for GAAP to non - GAAP reconciliation. 1. APUS excludes $2.8MM of losses in 4Q23 and $1.6MM in 2024 related to Loss on Disposal of Long - lived assets and Losses on assets held for sale. 2. Rasmussen excludes a non - cash impairment of $64MM in 2Q23. Also excludes $2.4MM for Collegis transition services expense in 2Q23, $2.9MM for lease termination and campus consolidation expense in 2Q24 and $3.7MM in leas e termination costs in 2024. 3. GSUSA and Corporate combined comprise the Corporate & Other segment, as discussed in footnote 16 within the 2024 10 - K disclosure . 16 Segment Summary ($ in millions) 1Q23 2Q23 3Q23 4Q23 FY23 1Q24 2Q24 3Q24 4Q24 FY24 1Q25 2Q25 Revenue $74.0 $73.6 $76.4 $79.4 303.3$ $80.7 $77.0 $77.0 $82.4 317.0$ $83.9 $81.7 EBITDA $18.5 $20.2 $23.3 $30.5 92.5$ $24.3 $19.5 $22.0 $28.4 94.3$ $25.2 $22.4 Margin 25% 28% 30% 38% 30% 30% 25.3% 29% 35% 30% 30% 27.4% Revenue $57.5 $52.0 $52.1 $52.6 214.1$ $53.1 $53.0 $52.6 $57.5 216.3$ $59.3 $59.5 EBITDA ($4.5) ($7.1) ($5.3) $0.4 (16.5)$ ($2.7) ($4.7) ($4.5) $5.5 (6.5)$ $2.1 $0.2 Margin -8% -14% -10% 1% -8% -5% -8.9% -9% 10% -3% 3% 0.3% Revenue $13.1 $14.3 $13.7 $15.8 56.9$ $16.4 $16.4 $15.5 $18.9 67.3$ $17.7 $18.1 EBITDA ($1.0) $0.1 ($0.3) $1.1 (0.1)$ $0.0 ($0.4) ($0.3) $1.2 0.6$ ($0.2) $0.1 Margin -8% 1% -2% 7% 0% 0% -2% -2% 6% 1% -1% 1% Revenue $5.1 $7.4 $8.6 $5.1 26.2$ $4.2 $6.4 $8.0 $5.3 24.0$ $3.7 $3.4 EBITDA ($1.3) $0.8 $1.6 ($1.1) 0.0$ ($1.1) ($0.7) $1.4 ($0.6) (1.0)$ ($2.1) ($2.5) Margin -25% 11% 18% -22% 0% -27% -11% 17% -11% -4% -57% -73% Corporate (6.9)$ (7.4)$ (5.7)$ (7.1)$ (27.1)$ (7.2)$ (5.5)$ (9.2)$ (9.0)$ (31.2)$ (8.6)$ (9.1)$ Consolidated Revenue $149.7 $147.2 $150.8 $152.8 600.5$ $154.4 $152.9 $153.1 $164.1 624.6$ $164.6 $162.8 Consolidated EBITDA $4.8 $6.7 $13.4 $23.8 48.7$ $13.2 $8.2 $9.4 $25.5 56.2$ $16.2 $11.1 (+) Adjustments 2.2$ 2.1$ 4.7$ 1.9$ 10.9$ 3.8$ 2.7$ 3.7$ 6.0$ 16.2$ 5.0$ 4.0$ Consolidated Adj. EBITDA 7.0$ 8.8$ 18.1$ 25.7$ 59.6$ 17.1$ 10.9$ 12.9$ 31.4$ 72.4$ 21.2$ 15.1$ Margin 5% 6% 12% 17% 10% 11% 7% 8% 19% 12% 13% 9% APEI APUS RU HCN GSUSA

 

 

Non - GAAP Disclosures American Public Education is presenting adjusted EBITDA and urges investors to review the reconciliation of adjusted net income to the comparable GAAP financial measure that is included in the table below (under the caption “GAAP Net Income to Adjusted EBITDA”) and not to rely on any single financial measure to evaluate its business . 17 GAAP Net Income to Adjusted EBITDA: The following table sets forth the reconciliation of the Company’s reported GAAP net income to the calculation of adjusted EBITDA for the three months ended between September 30, 2022 through March 31, 2025 (in thousands) Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Net income (loss) available to common stockholders (3,762) (6,583) (7,197) (52,719) (4,853) 11,475 (1,019) (1,160) 731 11,505 7,461 (324) Preferred stock dividends - 48 1,457 1,487 1,525 1,539 1,535 1,531 1,531 1,459 1,432 1,319 Loss on redemption of preferred stock - - - - - - - - - - - 3,501 Net (loss) income (3,762) (6,535) (5,740) (51,232) (3,328) 13,014 516 371 2,262 12,964 8,893 4,496 Income tax (benefit) expense (860) (1,124) (1,414) (15,137) 3,712 2,124 1,213 (16) 1,236 7,986 2,466 1,421 Interest expense, net 3,594 7,389 1,779 1,097 792 791 126 785 631 585 887 1,108 Equity investment loss 2 8 5 4 5,224 3 3,327 1,080 - - - - Depreciation and amortization 7,982 7,878 7,756 7,953 7,026 5,081 5,128 5,232 5,080 3,863 3,992 4,088 EBITDA 6,956 7,616 2,386 (57,315) 13,426 21,013 10,310 7,452 9,209 25,398 16,238 11,113 Impairment of goodwill and intangible assets - 2,000 - 64,000 - - - - - - Stock Compensation 1,997 1,306 2,224 2,068 1,733 1,715 1,918 1,823 1,761 2,166 2,263 2,238 Loss (gain) on disposals of long-lived assets 178 214 1 32 (16) 537 28 184 23 148 230 35 M&A - related professional fees 329 328 - - - - - - - - - - Other professional fees - - - - - - - - 813 1,404 989 1,715 Severance - - - - 2,959 - - 505 25 - - - Transition services costs - 3,936 2,403 - - - 1,865 182 1,092 659 - - Loss on leases - - - - - - 2,936 779 - - - - Loss on assets held for sale - - - - - 2,425 - - - 1,618 1,527 - Adjusted EBITDA 9,460 15,400 7,014 8,785 18,102 25,690 17,057 10,925 12,923 31,393 21,247 15,101 TTM ADJ EBITDA 40,659 49,301 59,591 69,634 71,774 66,595 72,298 76,488 80,664 Revenue 149,535 152,438 149,689 147,214 150,838 152,804 154,432 152,895 153,122 164,110 164,551 162,766 TTM Revenue 598,876 600,179 600,545 605,288 610,969 613,253 624,559 634,678 644,549 TTM ADJ EBITDA Margin 6.8% 8.2% 9.9% 11.5% 11.7% 10.9% 11.6% 12.1% 12.5%

 

 

Non - GAAP Disclosures GAAP Net Income to Adjusted EBITDA: The following table sets forth the reconciliation of the Company’s reported GAAP net income to the calculation of adjusted EBITDA for the three and six months ended June 30, 2025 and 2024:   (in thousands, except per share data)         Net (loss) income available to common stockholders $ (324) $ (1,160) $ 7,137 $ (2,179) Preferred dividends 1,319 1,531 2,751 3,066 Loss on redemption of preferred stock 3,501 - 3,501 - Net income $ 4,496 $ 371 $ 13,389 $ 887 Income tax expense 1,421 (16) 3,887 1,197 Interest expense, net 1,108 785 1,995 911 Equity investment loss - 1,080 - 4,407 Depreciation and amortization 4,088 5,232 8,080 10,360 EBITDA 11,113 7,452 27,351 17,762 Loss on assets held for sale - - 1,527 - Loss on leases - 779 - 3,715 Other professional fees 1,715 - 2,704 - Stock compensation 2,238 1,823 4,501 3,741 Loss on disposals of long-lived assets 35 184 265 212 Transition services costs - 182 - 2,047 Severance - 505 - 505 Adjusted EBITDA $ 15,101 $ 10,925 $ 36,348 $ 27,982 Three Months Ended June 30, 2025 2024 Six Months Ended June 30, 2025 2024 18 American Public Education is presenting adjusted EBITDA and urges investors to review the reconciliation of net income to the comparable GAAP financial measure that is included in the table below (under the caption “GAAP Net Income to Adjusted EBITDA”) and not to rely on any single financial measure to evaluate its business .

 

 

Non - GAAP Disclosures American Public Education is presenting Adjusted EBITDA in connection with its GAAP outlook and urges investors to review the reconciliation of projected EBITDA to the comparable GAAP financial measure that is included in the table below (under the caption “GAAP Outlook Net Income to Outlook Adjusted EBITDA”) and not to rely on any single financial measure to evaluate its business . 19 GAAP Outlook Net Income to Outlook Adjusted EBITDA:   (in thousands, except per share data)         Net income/(loss) available to common stockholders$ (2,859) $ (759) $ 18,528 $ 24,733 Preferred dividends - - 2,751 2,751 Loss on redemption of preferred stock - - 3,501 3,501 Net Income/(Loss) (2,859) (759) 24,780 30,985 Income tax expense/(benefit) (1,225) (325) 9,165 11,460 Interest expense 1,476 1,476 4,857 4,857 Loss on minority investment - - - - Depreciation and amortization 4,555 4,555 17,360 17,360 EBITDA 1,947 4,947 56,163 64,663 Stock compensation 2,229 2,229 8,890 8,890 Professional Services 980 980 4,280 4,280 Transition services cost 1,345 1,345 1,375 1,375 Loss on Sale of GSUSA 8,500 7,000 8,500 7,000 Other loses - - 1,792 1,792 Adjusted EBITDA $ 15,000 $ 16,500 $ 81,000 $ 88,000 The following table sets forth the reconciliation of the Company’s outlook GAAP net income to the calculation of outlook adjusted EBITDA for the three months ending September 30, 2025 and twelve months ending December 31, 2025: Three Months Ending Twelve Months Ending September 30, 2025 December 31, 2025 Low High Low High

 

 

Thank You Company Rick Sunderland Chief Financial Officer investorrelations@apei.com Investor Relations Brian M. Prenoveau, CFA MZ Group 561 - 489 - 5315 APEI@mzgroup.us